Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Estroven expands into weight management; Vitamints offer fresh take on nutrition; N(R) supplement is first product with Niagen; Designer Protein touts Sustained Energy; AssuriTEA Sport fights fatigue; more New Products In Brief.

You may also be interested in...



New Products In Brief

US Organic Group offers organic OTC anti-itch balm; Nordic Natural expands ProEPA line; Clearblue pregnancy test tracks time since ovulation; Nutrition 21 touts Nitrosigine as superior arginine; Culturelle probiotics go chewable; more New Products In Brief.

Certara Gets Further FDA Grant For Virtual Bioequivalence Studies

The FDA has awarded biosimulation specialist Certara a further grant to verify and expand models for assessing virtual bioequivalence, to help enable safer, faster and more cost-effective generic drug development.

New UK System Will Check Trial Sponsors Report Study Results

The UK has started monitoring whether clinical trial sponsors are fulfilling responsibilities to make their research open and transparent.

Topics

Related Companies

UsernamePublicRestriction

Register

PS106517

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel